Stamford's ApiJect Defends Its Record Over Promise Of COVID Syringes
A Stamford company is disputing an NBC News story focusing on the firm's failure to deliver a special kind of syringe -- so far -- during the pandemic. NBC reports that ApiJect was awarded contracts and loans under the Trump administration, to supply syringes prefilled with COVID-19 vaccine, but so far none have been made available for patients. The devices have not been approved for use. It is unclear if any requests for approval of their use have been made. At one point the company had said it would supply 100 million prefilled syringes by the end of last year. ApiJect now says it will be able to make up to three billion of the devices every year, if it gets a federal loan for almost $600 million to build a factory in North Carolina.